SIRPA and cancer: Recent studies reveal that CD47 can interact with its receptor, signal-regulatory protein alpha (SIRPα), on phagocytic cells like macrophages and dendritic cells to inhibit their ability to engulf cancer cells, promoting immune evasion and tumor growth.